BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33629759)

  • 21. Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience.
    Roayaie S; Haim MB; Emre S; Fishbein TM; Sheiner PA; Miller CM; Schwartz ME
    Ann Surg Oncol; 2000 Dec; 7(10):764-70. PubMed ID: 11129425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
    Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
    Nguyen MH; Garcia RT; Simpson PW; Wright TL; Keeffe EB
    Hepatology; 2002 Aug; 36(2):410-7. PubMed ID: 12143050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
    Di Poto C; He S; Varghese RS; Zhao Y; Ferrarini A; Su S; Karabala A; Redi M; Mamo H; Rangnekar AS; Fishbein TM; Kroemer AH; Tadesse MG; Roy R; Sherif ZA; Kumar D; Ressom HW
    PLoS One; 2018; 13(3):e0192748. PubMed ID: 29538406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
    El-Serag HB; Kramer J; Duan Z; Kanwal F
    Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients.
    Cunha L; Carrilho C; Bhatt N; Loforte M; Maueia C; Fernandes F; Guisseve A; Mbofana F; Maibaze F; Mondlane L; Ismail M; Dimande L; Machatine S; Lunet N; Liu YT; Gudo ES; Pineau P
    Cancer Treat Res Commun; 2019; 19():100129. PubMed ID: 30903933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma.
    Hiotis SP; Rahbari NN; Villanueva GA; Klegar E; Luan W; Wang Q; Yee HT
    BMC Gastroenterol; 2012 Jun; 12():64. PubMed ID: 22681852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HCV infection and cryptogenic cirrhosis are risk factors for hepatocellular carcinoma among Latinos in New York City.
    Guerrero-Preston R; Siegel A; Renz J; Vlahov D; Neugut A
    J Community Health; 2009 Dec; 34(6):500-5. PubMed ID: 19705261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis.
    Hsu HC; Jeng YM; Mao TL; Chu JS; Lai PL; Peng SY
    Am J Pathol; 2000 Sep; 157(3):763-70. PubMed ID: 10980116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
    Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
    Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More advanced disease and worse survival in cryptogenic compared to viral hepatocellular carcinoma.
    Jun TW; Yeh ML; Yang JD; Chen VL; Nguyen P; Giama NH; Huang CF; Hsing AW; Dai CY; Huang JF; Chuang WL; Roberts LR; Yu ML; Nguyen MH
    Liver Int; 2018 May; 38(5):895-902. PubMed ID: 29045023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Less Fibrotic Burden Differently Affects the Long-Term Outcomes of Hepatocellular Carcinoma after Curative Resection.
    Lee HW; Choi GH; Kim DY; Park YN; Kim KS; Choi JS; Ahn SH; Han KH
    Oncology; 2017; 93(4):224-232. PubMed ID: 28571030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe inflammation in the background liver cirrhosis correlates with the development of poorly differentiated HCC in HCV-associated liver cirrhosis.
    Tarao K; Miyakawa K; Miyagi Y; Ohkawa S; Morinaga S; Oshige K; Yamamoto N; Ueno M; Kobayashi S; Kameda R; Tamai S; Nakamura Y; Endo Y; Kameda Y; Okudaira M
    Intern Med; 2012; 51(18):2495-501. PubMed ID: 22989817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
    Reddy A; May E; Ehrinpreis M; Mutchnick M
    World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A; Orloff M; Abt P; Tsoulfas G; Younan D; Kashyap R; Jain A; Mantry P; Maliakkal B; Khorana A; Schwartz S
    Liver Transpl; 2007 Jun; 13(6):807-13. PubMed ID: 17539001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma.
    Liu C; Xiao GQ; Yan LN; Li B; Jiang L; Wen TF; Wang WT; Xu MQ; Yang JY
    World J Gastroenterol; 2013 Mar; 19(11):1811-9. PubMed ID: 23555170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical presentation and survival of Asian and non-Asian patients with HCV-related hepatocellular carcinoma.
    Yip B; Wantuck JM; Kim LH; Wong RJ; Ahmed A; Garcia G; Nguyen MH
    Dig Dis Sci; 2014 Jan; 59(1):192-200. PubMed ID: 24282055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.